Tiago A. Carvalho
Covilha, 6200506, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
G Protein-Coupled Oestrogen Receptor Actions Targeting the Hallmarks of Cancer in Human Prostate Cells: From Cell Fate to Metabolic Reprogramming.
Journal: Cancers
Published: February 01, 2026
Endocrine-disrupting chemicals as prostate carcinogens.
Journal: Nature reviews. Urology
Published: March 25, 2025
The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.
Journal: Biomedicines
Published: June 26, 2024
Androgens and low density lipoprotein-cholesterol interplay in modulating prostate cancer cell fate and metabolism.
Journal: Pathology, research and practice
Published: July 28, 2022
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 17, 2020
Revisiting prostate cancer metabolism: From metabolites to disease and therapy.
Journal: Medicinal research reviews
Published: July 03, 2020
Adenosine inhibits human astrocyte proliferation independently of adenosine receptor activation.
Journal: Journal of neurochemistry
Published: July 15, 2019
Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment.
Journal: Life sciences
Published: November 29, 2018
Impaired protein quality control system underlies mitochondrial dysfunction in skeletal muscle of streptozotocin-induced diabetic rats.
Journal: Biochimica et biophysica acta
Published: December 09, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026